Skip to main content
OpenTrials
Completed

NCT Number: NCT01180543

Acne Treatment With Active Oplon's Patches

The purpose of this study was to demonstrate the effect of short treatment with active OPLON patches on Acne.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Dermatology Clinic

Netanya, Israel

About this study

Patients with Acne Vulgaris were treated overnight with active patches. Effect is observed at the end of the treatment and 24 hours later.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acne Vulgaris
  • Over 18 years
  • Signing informed consent

Exclusion criteria

  • Active treatment of acne
  • Change in hormonal therapy
  • Antibiotic treatment in a week prior to the experiment
  • Sensitive skin
  • Pregnancy

Treatment and study plan

Oplon Active Patch

Device

Patches are placed over acne lesion overnight. Treatment is a single treatment.

Placebo Patch

Device

same as active patch

Primary outcomes

  1. Severity Score of lesion

    Time frame: Severity Score of lesion [Time Frame: 24 hours following patch removal]

    Lesions were ranked by investigator according to severity whereas:

    0-clear, 1-mild, 2-moderate, 3-sever

Secondary outcomes

  1. Severity Score of lesion

    Time frame: Severity Score of lesion [Time Frame: 12 hours with the patch]

    Lesions were ranked by investigator according to severity whereas:

    0-clear, 1-mild, 2-moderate, 3-sever

Sponsors and collaborators

Lead sponsor

Oplon-Pure Science Ltd.

Industry

Registry information

Official study title

Phase II- Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Aug 12, 2010
Registry last updated
Jun 10, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.